High materiality7/10
UBS Starts Assembly Biosciences (ASMB) at Buy
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS initiates coverage on ASMB with Buy rating; target $52; current price $33.63; price up $4.61 since signal.
- UBS starts ASMB at Buy; target $52; price $33.63.
Key facts
- 01
Target: $52
- 02
Posted price: $33.63
- 03
Analyst firm: UBS
- 04
Analyst: Ashwani Verma
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.